R&D Tax Credit Optimization

Most founders assume R&D credits are built for pharmaceutical giants and billion-dollar tech labs. That assumption is costing them tens of thousands of dollars a year. The IRS definition of qualified research is broader than most people realize - and the payroll tax offset means even pre-revenue startups can convert this credit into real, immediate cash. What Actually Qualifies The IRS applies a four-part test. You don't need a breakthrough product. You need to meet these criteria: a permitted purpose (developing or improving a product, process, or software), work that's technological in nature (engineering, computer science, physical or biological science), elimination of uncertainty (testing approaches where the answer isn't obvious), and a process of experimentation (modeling, prototyping, structured trial and error). Failed experiments count. The IRS cares about the process, not the outcome. How the Payroll Tax Offset Works Traditionally, credits only helped if you had income tax liability. The PATH Act changed that in 2015. Qualified small businesses can now apply up to $500,000 of their R&D credit against the employer portion of Social Security taxes - regardless of profitability. To qualify: gross receipts under $5 million, no gross receipts before the five-year period ending with the current year, and less than five years from first gross receipts. You claim it on Form 941 and see the cash flow improvement immediately. What Documentation You Need The IRS won't accept vague claims. You need contemporaneous documentation - created at the time, not reconstructed later. Keep project records describing the technical problem, the approaches you tested, and what you observed. Track time on qualified activities. Document your expenses through payroll records, supply invoices, and contractor agreements. Version control records, bug logs, and testing notes all support your claim. How to Engage a Specialist Most CPAs don't handle R&D credits - not because of any gap in competence, but because the technical analysis required to properly calculate and defend a claim is specialized work outside standard tax preparation. Your CPA handles your overall tax position. A specialist identifies qualified activities, quantifies expenses, and documents the claim so it holds up under scrutiny. Complementary roles. I do this work every day - analyzing activities, quantifying credits, and building the documentation that protects you if the IRS asks questions. If you're wondering whether your business qualifies, send me a message. I'll tell you honestly if it's worth moving forward.

They paid a Big 4 to handle their taxes. We found an extra $5M in tax credits they missed. “We already work with a Big 4 firm. Why would we need you?” I hear this a lot. And I get it… many companies assume that if you’re with a Big 4 firm, everything is being handled. But here’s the truth: Big 4 firms prioritize compliance and focus on large corporate clients. They are great at tax preparation. But when it comes to highly specialized areas like: - R&D tax credits - Negotiated incentives They often say no before fully investigating. That’s exactly what happened with a logistics company in New Jersey. They were developing internal-use software since the 1990s. PwC told them they didn’t qualify for the R&D tax credit. But they weren’t just checking boxes. The logistics company was innovating (but no one at PwC had taken the time to understand the depth of their work.) So we did. - We spent months interviewing developers & business leaders - We built a detailed technical case - We filed for $5M in retroactive R&D tax credits Yes, the IRS audited (we spent 2 weeks on-site defending the claim). But 99% of those credits were approved. So no, my clients didn’t leave PwC for everything. But when it came to tax credits and incentives… They needed a specialist. And that made all the difference.

The One Big Beautiful Bill just reversed Section 174 — one of the most damaging tax changes for R&D-heavy companies. The Tax Cuts and Jobs Act of 2017 required companies to capitalize and amortize R&D expenses over 5 years for domestic R&D and 15 years for foreign R&D, starting in tax year 2022. This disproportionately affected tech companies, whose primary expenses are related to building and innovation (i.e., R&D). Even unprofitable companies could face tax bills due to having to amortize R&D expenses over time rather than deducting them immediately. Under the One Big Beautiful Bill (for stock acquired after July 4, 2025): → Domestic R&D can be expensed immediately. → Software development is explicitly included as qualifying R&D. → Small businesses (with average annual gross receipts of $31 million or less) can retroactively apply the new rules to tax years 2022–2024 and reclaim deductions for R&D expenses that were previously amortized. Startups should begin to see a reduced tax burden — exactly when capital is most critical. R&D-intensive businesses shouldn’t be penalized for investing in innovation.

I had a call with a business owner last month who has close to $1M in R&D credits sitting on the table across three open tax years. He is not filing. His CPA told him amending would "trigger a full audit." I hear this every single week. So I did something about it. I pulled every published IRS source on how R&D credit claims on amended returns are actually reviewed. Six documents. Here is what they say: The IRS built an entirely separate process for these claims. It is called the RCCATG. It is staffed by subject matter experts. The scope is limited to the credit. They are not looking at your deductions, your income, or anything else on your return. If something is missing, they send you a letter. You get 45 days to fix it. Worst case: the credit is denied. Your return stays closed. That is not an audit. That is a review with a defined scope and a defined process. The real risk? The statute of limitations on his 2022 return closes in weeks. Once that happens, those credits are gone permanently. No amount of filing will bring them back. I wrote the whole thing up with every IRS source linked. If your CPA has told you amending is risky, send them this article. Most CPAs, once they see the actual published guidance, become comfortable with the process. Link in the comments 👇 #RDTaxCredit #TaxPlanning #OBBBA #TaxCredits #ResearchDevelopment

Attention Small Business Owners: You Might Be Leaving Money on the Table! The IRS just dropped a new rule (Rev. Proc. 2025-28, issued August 28) that could mean extra cash for businesses doing research and development (R&D). If you’ve done ANY R&D work in the last few years, here’s what you need to know: You can now amend your 2022–2024 tax returns to claim the R&D credit—even if you didn’t claim it originally. That’s money back in your pocket. Do you qualify? Your work needs to meet these 4 tests: - It’s technical (think science or engineering—not marketing or admin tasks). - You faced uncertainty about how to achieve the result. - Experimentation was involved (trying different methods or designs). - It’s a new or improved product, process, or software (new to YOU, not something off-the-shelf). Key Details: Only U.S.-based R&D qualifies (foreign R&D costs still need to be amortized over 15 years). Deadlines to amend: 2022 returns: March 15 or April 15, 2026 (depending on your entity type). 2023 & 2024 returns: July 6, 2026. This won’t apply to every business, but if you qualify, it’s a chance to recover credits you might’ve missed. Don’t wait—talk to your tax advisor or accountant to see if this applies to you.

The R&D tax credit math is wild. Let me show you what the One Big Beautiful Bill (OBBB) means for tech companies who've been building since 2022: A software company with $3MM in R&D expenses in 2022: • Pre-TCJA would have deducted the full $3MM • Post-TCJA could only deduct $300K (10% in year one) This created two problems: 1. Companies owed taxes on phantom profits 2. Many skipped claiming the R&D credit altogether The OBBB fix creates TWO recovery opportunities: 1. The DEDUCTION fix: • $3MM in R&D for 2023 • Previously deducted: $300K • Trapped in amortization: $2.7MM • At 28% tax rate: ~$750K potential refund from amended returns 2. The CREDIT opportunity: • Separate from the deduction • Worth 8-10% of qualified expenses • That's another 240K−300K per $3MM in R&D • Available every year Total opportunity: ~$1MM per year on $3MM in R&D spending. For startups (≤$5MM receipts): No profit? No problem. The credit can offset payroll taxes up to $500K/year. Quarterly refunds. Even pre-revenue companies can get checks. Action items THIS WEEK: 1. Pull your 2022-2024 returns 2. Find "Section 174 capitalization" 3. Multiply by your tax rate 4. Check if you claimed credits 5. Call a specialist This isn't just another tax strategy—it's potentially the most significant cash recovery opportunity your business will see this decade.

Qualified small businesses with domestic R&D activities now have a rare, time-sensitive opportunity to unlock significant tax benefits. A recent change allows you to: ✅ Amend your 2022, 2023, and 2024 tax returns ✅ Fully expense all eligible domestic R&D costs ✅ Generate immediate cash flow This provision applies to R&D work already completed such as product development, software creation, process improvements, and other activities meeting the IRS definition of qualified research under Section 174. The critical detail: There is only a one-year window from the date this law was enacted to take advantage of this opportunity. Once that period ends, the ability to claim these retroactive benefits is gone. For eligible companies, this can mean freeing up capital to reinvest in operations, innovation, or growth without raising external funding. However, proper documentation and a clear understanding of qualification criteria are essential to maximize benefits and remain compliant. Businesses should act quickly to assess eligibility, gather records, and file amended returns with the guidance of a tax professional experienced in R&D expensing. #RDTaxCredit #TaxStrategy #SmallBusiness #StartupFunding #Innovation #BusinessGrowth #TaxPlanning #RDExpensing #AccountingIndustry

If you’ve been stressed about your tax bill because of R&D costs, 2026 brings some much-needed relief. For the past few years, businesses had to spread out (amortize) their U.S. research costs over five years. That meant smaller deductions upfront and higher tax bills in the early years. Now, that’s changing. Starting in 2025 and moving into 2026, companies can once again deduct 100% of their U.S.-based R&D costs in the same year they spend the money. Here’s what that means in simple terms: U.S. R&D If your engineers and developers are based in the U.S., you can deduct the full cost in year one. No more five-year waiting period. Foreign R&D If your development work is done outside the U.S., those costs still have to be spread out over 15 years. So where your team is located now matters even more. Software Development Counts Coding, testing, and software design are clearly included. If you have a U.S. dev team, their costs are fully deductible again. Old R&D Costs (2022–2024) If you still have R&D costs from those years that were being spread out, you may have options: • Deduct the remaining amount all at once in 2025, or • Split it between 2025 and 2026 to manage your taxable income. Smaller businesses (under $31M in gross receipts) might even be able to amend prior returns and potentially get refunds. Why This Matters Let’s say you spend $1 million on R&D. Under the old rule, you might have only deducted about $100,000 in the first year. Under the new rule, you can deduct the full $1 million in year one. That can significantly lower your taxable income and estimated tax payments. This isn’t just about taxes. It’s about strategy. Does keeping your development team in the U.S. - and getting the full deduction - make more sense now? Or do lower overseas labor costs still outweigh the longer tax write-off? 2026 gives businesses a chance to rethink how and where they invest in innovation. #TaxUpdate #RandD #StartupFinance #BusinessTax #Entrepreneurship #FinancialPlanning

DEADLINE ALERT: The R&D Tax Window Almost Nobody Is Talking About CLOSES July 6. Here's a number that should stop every founder and CFO in their tracks: ONLY 1 in 3 eligible companies ACTUALLY claim R&D expensing. The other two? They assume they DO NOT qualify. They're often WRONG. The One Big Beautiful Bill Act restored first-year expensing for domestic R&D — and opened a retroactive window letting businesses under $31M in average gross receipts amend their 2022–2024 returns to recover real cash refunds. That window closes July 6, 2026. One year from enactment. Then it's gone. A few things most people get wrong: → The $31M threshold isn't annual. It's a three-year average. Far more companies clear it than think they do. → You don't have to be a tech or life sciences company. Manufacturing, software, even businesses building their own internal apps can qualify. It's activity-based — if you're developing new processes or products, you may already be doing qualified R&D without calling it that. → Consultants count. The relief covers both 1099 and W-2 workers, as long as the work is performed in the U.S. One important caveat: this is complex, and the IRS is demanding more documentation than ever. Even if you don't claim the credit this year, filing the election statement preserves your ability to expense going forward. That part is worth doing regardless. And a word of caution — don't run your R&D study through an AI chatbot and call it done. The National Taxpayer Advocate has flagged over-reliance on AI for tax advice, and unverified AI-generated studies are a documented audit red flag. This is a place for real professional judgment. If you've never looked at R&D expensing because you assumed it wasn't for you, the next two weeks are the time to find out. After July 6, the retroactive door is shut. Is your business leaving this money on the table? DM me if you want to get this going!